Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 11, 2011, Pages 857-866

  Cai, Anping ^a   Zheng, Dongdan ^a   Dong, Yugang ^a   Qiu, Ruofeng ^a   Huang, Yuli ^a   Song, Yuanbin ^a   Jiang, Zhigao ^a   Rao, Shaoqi ^a   Liao, Xinxue ^a   Kuang, Jian ^a   Dai, Gang ^a   Mai, Weiyi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

acute myocardial infarction; Atorvastatin; mesenchymal stem cell

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; PYRROLE DERIVATIVE; TRANSCRIPTION FACTOR GATA 4; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOSE TISSUE; ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; HEART FUNCTION TEST; HEART INFARCTION; HEART MUSCLE CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; RAT; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ADIPOSE TISSUE; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; GATA4 TRANSCRIPTION FACTOR; HEART FUNCTION TESTS; HEPTANOIC ACIDS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

RATTUS;

EID: 80455177329     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr087     Document Type: Article

References (26)

1. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H and Ishino K, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12:459-465.
2. Madonna R, Geng YJ and De Caterina R. Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arterioscler Thromb Vasc Biol 2009, 29:1723-1729.
3. Li TS, Hayashi M, Ito H, Furutani A, Murata T, Matsuzaki M and Hamano K. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation 2005, 111:2438-2445.
4. Alfaro MP, Vincent A, Saraswati S, Thorne CA, Hong CC, Lee E and Young PP. sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. J Biol Chem 2010, 285:35645-35653.
5. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS and Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003, 9:1195-1201.
6. Song SW, Chang W, Song BW, Song H, Lim S, Kim HJ and Cha MJ, et al. Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells 2009, 27:1358-1365.
7. Chang W, Song BW, Lim S, Song H, Shim CY, Cha MJ and Ahn DH, et al. Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury. Stem Cells 2009, 27:2283-2292.
8. Li H, Zuo S, He Z, Yang Y, Pasha Z, Wang Y and Xu M. Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival. Am J Physiol Heart Circ Physiol 2010, 299:H1772-H1781.
9. Eun LY, Song BW, Cha MJ, Song H, Kim IK, Choi E and Chang W, et al. Overexpression of phosphoinositide-3-kinase class II alpha enhances mesenchymal stem cell survival in infarcted myocardium. Biochem Biophys Res Commun 2010, 402:272-279.
10. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C and Gaussin V, et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 2010, 56:721-734.
11. Yang YJ, Qian HY, Huang J, Geng YJ, Gao RL, Dou KF and Yang GS, et al. Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J 2008, 29:1578-1590.
12. Bartunek J, Croissant JD, Wijns W, Gofflot S, de Lavareille A, Vanderheyden M and Kaluzhny Y, et al. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol 2007, 292:H1095-H1104.
13. Zuk PA. The Adipose-derived stem cell: looking back and looking ahead. Mol Biol Cell 2010, 21:1783-1788.
14. Gimble JM, Katz AJ and Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100:1249-1260.
15. Yang L, Zou X, Liang Q, Chen H, Feng J, Yan L and Wang Z, et al. Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway. Exp Mol Med 2007, 39:65-73.
16. Liu XH, Bai CG, Xu ZY, Huang SD, Yuan Y, Gong DJ and Zhang JR. Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction. Microvasc Res 2008, 76:23-30.
17. Toma C, Pittenger MF, Cahill KS, Byrne BJ and Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
18. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K and Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001, 33:907-921.
19. Yang YJ, Qian HY, Huang J, Li JJ, Gao RL, Dou KF and Yang GS, et al. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol 2009, 29:2076-2082.
20. Sola S, Mir MQ, Lerakis S, Tandon N and Khan BV. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 2006, 47:332-337.
21. Zhang J, Cheng X, Liao YH, Lu B, Yang Y, Li B and Ge H, et al. Simvastatin regulates myocardial cytokine expression and improves ventricular remodeling in rats after acute myocardial infarction. Cardiovasc Drugs Ther 2005, 19:13-21.
22. Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A and Spiekermann S, et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 2004, 110:1933-1939.
23. Tawfik MK, Ghattas MH, Abo-Elmatty DM and Abdel-Aziz NA. Atorvastatin restores the balance between pro-inflammatory and antiinflammatory mediators in rats with acute myocardial infarction. Eur Rev Med Pharmacol Sci 2010, 14:499-506.
24. Chan KC, Chou HH, Huang CN and Chou MC. Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: impact on plasma adiponectin level. Clin Cardiol 2008, 31:253-258.
25. Teshima Y, Yufu K, Akioka H, Iwao T, Anan F, Nakagawa M and Yonemochi H, et al. Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction. J Cardiol 2009, 53:58-64.
26. Li TS, Takahashi M, Suzuki R, Kobayashi T, Ito H, Mikamo A and Hamano K. Pravastatin improves remodeling and cardiac function after myocardial infarction by an antiinflammatory mechanism rather than by the induction of angiogenesis. Ann Thorac Surg 2006, 81:2217-2225.